Effects of Nicorandil on Cardiovascular Events in Patients With Coronary Artery Disease Receiving Hemodialysis

NCT01475123 Phase 4 ACTIVE_NOT_RECRUITING

Nicorandil is potentially effective to prevent cardiovascular events in patients with coronary artery disease (CAD) receiving hemodialysis. The purpose of this study is to prospectively investigate whether nicorandil is effective in reducing the incidence of cardiovascular events in patients with CAD on hemodialysis.

Details

Lead sponsor	Kumamoto University
Phase	Phase 4
Status	ACTIVE_NOT_RECRUITING
Enrolment	268
Start date	2008-06
Completion	2026-03

Conditions

• Coronary Artery Disease
• End Stage Renal Disease

Interventions

• Nicorandil

Primary outcomes

• The primary endpoint is composite of :1) cardiovascular death 2)sudden cardiac death 3)nonfatal myocardial infarction 4)Hospitalization for recurrent symptomatic myocardial ischemia 5)stroke — 2 years

Countries

Japan